Clinical Trial Update: The Effects of Mesenchymal Stem Cell Secretome in Lupus Patients [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating mesenchymal stem cell secretome for lupus erythematosus has completed, indicating exploratory safety and efficacy assessme…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lupus Erythematosus

Snippet

Sponsor: Universitas Sebelas Maret | Conditions: Lupus Erythematosus | Phase 1, Phase 2 | Status: COMPLETED